← All companies

EXEL

Exelixis, Inc.

EXEL Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$55.06

-0.91 -1.63%

Key statistics

from XBRL data in SEC filings

Market cap

$13.8B

Revenue (TTM)

$2.38B

Net income (TTM)

$833M

EPS (TTM)

$3.02

P/E ratio

18.2

Dividend yield

—

Free cash flow

$876M

Cash

$226M

Total assets

$2.59B

Gross margin

29.7%

52-week range

$33.76 – $57.57

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results May 29, 2026 10-Q Quarter ended 2026-04-03 May 5, 2026 8-K Results of operations (earnings release); Other events May 5, 2026 10-K Fiscal year ended 2026-01-02 Feb 10, 2026 8-K Results of operations (earnings release) Feb 10, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Director or officer change; Other events Nov 7, 2025 10-Q Quarter ended 2025-10-03 Nov 4, 2025 8-K Results of operations (earnings release); Other events Nov 4, 2025 8-K Director or officer change Aug 29, 2025 10-Q Quarter ended 2025-07-04 Jul 28, 2025 8-K Results of operations (earnings release) Jul 28, 2025 8-K Shareholder vote results Jun 2, 2025 10-Q Quarter ended 2025-04-04 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Director or officer change Mar 31, 2025 8-K Other events Feb 21, 2025 10-K Fiscal year ended 2025-01-03 Feb 11, 2025 8-K Results of operations (earnings release) Feb 11, 2025 8-K Results of operations (earnings release) Jan 13, 2025 10-Q Quarter ended 2024-09-27 Oct 29, 2024 8-K Results of operations (earnings release) Oct 29, 2024 8-K Other events Oct 15, 2024 8-K Other events Oct 15, 2024 10-Q Quarter ended 2024-06-28 Aug 6, 2024 8-K Results of operations (earnings release); Other events Aug 6, 2024 8-K Director or officer change; Shareholder vote results Jun 3, 2024 8-K Other events May 20, 2024 8-K Other events May 10, 2024 10-Q Quarter ended 2024-03-29 Apr 30, 2024 8-K Results of operations (earnings release) Apr 30, 2024 8-K Director or officer change Mar 29, 2024 10-K Fiscal year ended 2023-12-29 Feb 6, 2024 8-K Results of operations (earnings release) Feb 6, 2024 8-K Results of operations (earnings release); Exit or disposal costs; Director or officer change; Other events Jan 8, 2024 8-K Director or officer change; Amended charter or bylaws Dec 20, 2023 10-Q Quarter ended 2023-09-29 Nov 1, 2023 8-K Results of operations (earnings release) Nov 1, 2023 8-K Director or officer change Sep 19, 2023 8-K Director or officer change Aug 23, 2023